Long-Term Assets: The sum of all assets classified as non-current.
Alzamend Neuro, Inc. (ALZN) had Long-Term Assets of $0.40M for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
-- |
|
$-2.70M |
|
-- |
|
-- |
|
$2.70M |
|
$-2.70M |
|
$-0.00M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.67M |
|
2.11M |
|
2.11M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$5.93M |
|
$0.40M |
|
|
Long-Term Assets |
$0.40M |
$6.33M |
|
$0.98M |
|
-- |
|
-- |
|
$0.98M |
|
$5.34M |
|
$5.34M |
|
$5.34M |
|
3.14M |
|
| Cash Flow Statement Financials | |
$-2.36M |
|
-- |
|
$4.04M |
|
$3.95M |
|
$5.62M |
|
$1.67M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-50.58% |
|
-50.58% |
|
-42.72% |
|
-50.58% |
|
$1.70 |
|
$-1.12 |
|
$-1.12 |
|